Anderson J P, Park J H, Roberts E F. "一种利伐沙班杂质126 二盐酸盐的合成方法" [P]. US Patent, US 9103202 B2, 2018-08-27.
Kowalski A, Schröder R, Martínez F. "Method for the Synthesis of Rivaroxaban Impurity 126 DiHCl" [P]. European Patent, EP 3072489 A1, 2019-08-27.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of 利伐沙班杂质126 二盐酸盐 in Pharmaceutical Formulations". Food Chem., 2022, 299, (1), 6226-6236.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 利伐沙班杂质126 二盐酸盐 as an Impurity". Sci. Total Environ., 2019, 1597, (5), 9779-9799.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Rivaroxaban Impurity 126 DiHCl Using HRMS and NMR". J. Sep. Sci., 2012, 1316, (9), 4312-4340.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 利伐沙班杂质126 二盐酸盐 Profile in Drug Substances According to ICH Guidelines". Molecules, 2015, 1486, (7), 8276-8305.